Literature DB >> 16463365

Short-term microvascular response of striated muscle to cp-Ti, Ti-6Al-4V, and Ti-6Al-7Nb.

Peter H Pennekamp1, Jan Gessmann, Oliver Diedrich, Björn Burian, Markus A Wimmer, Vinzenz M Frauchiger, Clayton N Kraft.   

Abstract

Due to excellent mechanical properties and good corrosion resistance, titanium-aluminium-vanadium (Ti-6Al-4V) and titanium-aluminium-niobium (Ti-6Al-7Nb) are extensively used for orthopedic surgery. Concern has been voiced concerning the implications of the constituent vanadium in Ti-6Al-4V on the surrounding environment. Particularly in osteosynthesis where the alloys stand in direct contact to skeletal muscle, undesirable biologic reactions may have severe consequences. In a comparative study, we assessed in vivo nutritive perfusion and leukocytic response of striated muscle to the metals Ti-6Al-4V, Ti-6Al-7Nb, and commercially pure titanium (cpTi), thereby drawing conclusions on their short-term inflammatory potential. In 28 hamsters, utilizing the dorsal skinfold chamber preparation and intravital microscopy, we quantified primary and secondary leukocyte-endothelial cell interaction, leukocyte extravasation, microvascular diameter change, and capillary perfusion in collecting and postcapillary venules of skeletal muscle. A manifest discrepancy between the metals concerning impact on local microvascular parameters was not found. All metals induced an only transient and moderate inflammatory response. Only a slight increase in leukocyte recruitment and a more sluggish recuperation of inflammatory parameters in animals treated with Ti-6Al-4V compared to the other two metals suggested a minor, overall not significant discrepancy in biocompatibility. Gross toxicity of bulk Ti-6Al-4V on surrounding tissue could not be found. Conclusively, the commonly used biomaterials Ti-6Al-4V, Ti-6Al-7Nb, and cpTi induce an only transient inflammatory answer of the skeletal muscle microvascular system. Our results indicate that on the microvascular level the tested bulk Ti-alloys and cpTi do not cause adverse biologic reactions in striated muscle. Copyright 2006 Orthopaedic Research Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16463365     DOI: 10.1002/jor.20066

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  6 in total

Review 1.  Reference biomaterials for biological evaluation.

Authors:  Leena Joseph; Arumugham Velayudhan; Muraleedharan V Charuvila; Muraleedharan C Vayalappil
Journal:  J Mater Sci Mater Med       Date:  2008-07-22       Impact factor: 3.896

2.  Chimeric peptides as implant functionalization agents for titanium alloy implants with antimicrobial properties.

Authors:  Deniz T Yucesoy; Marketa Hnilova; Kyle Boone; Paul M Arnold; Malcolm L Snead; Candan Tamerler
Journal:  JOM (1989)       Date:  2015-04       Impact factor: 2.471

3.  New TiAg composite coating for bone prosthesis engineering shows promising microvascular compatibility in the murine dorsal skinfold chamber model.

Authors:  Ann-Kathrin Behrendt; Maximilian Beythien; Jakob Huber; Thorsten Zufraß; Antje Butschkau; Thomas Mittlmeier; Brigitte Vollmar
Journal:  J Mater Sci Mater Med       Date:  2015-01-15       Impact factor: 3.896

4.  Surface modification of titanium thin film with chitosan via electrostatic self-assembly technique and its influence on osteoblast growth behavior.

Authors:  Kaiyong Cai; Yan Hu; Klaus D Jandt; Yuanliang Wang
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

Review 5.  Functional role of inorganic trace elements in angiogenesis part III: (Ti, Li, Ce, As, Hg, Va, Nb and Pb).

Authors:  Mohammad Ali Saghiri; Jafar Orangi; Armen Asatourian; Christine M Sorenson; Nader Sheibani
Journal:  Crit Rev Oncol Hematol       Date:  2015-10-20       Impact factor: 6.312

6.  Biomaterials for craniofacial reconstruction.

Authors:  Andreas Neumann; Kevin Kevenhoerster
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.